Modulating gut microbial metabolism in heart failure: Opportunities and challenges

by W. H. Wilson Tang, Thanat Chaikijurajai
Published 2021-09-01

Protecting the heart in cancer therapy [version 1; referees: 2 approved]

by J. Emanuel Finet, W. H. Wilson Tang
Published 2018-09-01

Reconsidering Renal Sympathetic Denervation for Heart Failureâ

by W.H. Wilson Tang, MD, Mark E. Dunlap, MD
Published 2017-06-01

Epigenetics in Cardiac Hypertrophy and Heart Failure

by Chia-Feng Liu, PhD, W.H. Wilson Tang, MD
Published 2019-12-01

Prognostic value of subclinical myocardial necrosis using high-sensitivity cardiac troponin T in patients with prediabetes

by Marco Witkowski, Yuping Wu, Stanley L. Hazen, W. H. Wilson Tang
Published 2021-08-01

Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension

by Hoi I Cheong, Samar Farha, Margaret M. Park, James D. Thomas, Didem Saygin, Suzy A. A. Comhair, Jacqueline Sharp, Jacqueline Sharp, Kristin B. Highland, W. H. Wilson Tang, W. H. Wilson Tang, Serpil C. Erzurum, Serpil C. Erzurum
Published 2018-12-01

Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis

by Unnikrishnan M. Chandrasekharan, Zeneng Wang, Yuping Wu, W. H. Wilson Tang, Stanley L. Hazen, Sihe Wang, M. Elaine Husni
Published 2018-06-01

Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy

by Stephen J. Nicholls, W.H. Wilson Tang, Heather Scoffone, Danielle M. Brennan, Jaana Hartiala, Hooman Allayee, Stanley L. Hazen
Published 2010-10-01

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers

by Kenneth D. Varian, Xinge Ji, Justin L. Grodin, Frederik H. Verbrugge, Alex Milinovich, Michael W. Kattan, W.H. Wilson Tang
Published 2020-10-01

Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients

by Johnny Chahine, MD, Patrick Collier, MD, PhD, Anjli Maroo, MD, W.H. Wilson Tang, MD, Allan L. Klein, MD
Published 2020-02-01

Impact of body mass index on surgical coronary revascularization for ischaemic heart failure: insights from STICHES

by Nicholas S. Hendren, Lin Zhong, Ian J. Neeland, Katherine C. Michelis, Mark H. Drazner, W.H. Wilson Tang, Ambarish Pandey, Justin L. Grodin
Published 2020-12-01

Discordance between 'actual' and 'scheduled' check-in times at a heart failure clinic.

by Eiran Z Gorodeski, Emer Joyce, Benjamin T Gandesbery, Eugene H Blackstone, David O Taylor, W H Wilson Tang, Randall C Starling, Rory Hachamovitch
Published 2017-01-01

Mitochondrial DNA Content Is Linked to Cardiovascular Disease Patient Phenotypes

by Ruipeng Wei, Ying Ni, Peter Bazeley, Sneha Grandhi, Janet Wang, Samuel T. Li, Stanley L. Hazen, W. H. Wilson Tang, Thomas LaFramboise
Published 2021-02-01

Coenzyme Q supplementation in pulmonary arterial hypertension

by Jacqueline Sharp, Samar Farha, Margaret M. Park, Suzy A. Comhair, Erika L. Lundgrin, W.H. Wilson Tang, Robert D. Bongard, Marilyn P. Merker, Serpil C. Erzurum
Published 2014-01-01

Impact of Individual Traits, Saturated Fat, and Protein Source on the Gut Microbiome

by Jennifer M. Lang, Calvin Pan, Rita M. Cantor, W. H. Wilson Tang, Jose Carlos Garcia-Garcia, Ira Kurtz, Stanley L. Hazen, Nathalie Bergeron, Ronald M. Krauss, Aldons J. Lusis
Published 2018-12-01

Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease

by Jaana A. Hartiala, W. H. Wilson Tang, Zeneng Wang, Amanda L. Crow, Alexandre F. R. Stewart, Robert Roberts, Ruth McPherson, Jeanette Erdmann, Christina Willenborg, Stanley L. Hazen, Hooman Allayee
Published 2016-01-01

Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseases[S]

by Ibrahim Choucair, Ina Nemet, Lin Li, Margaret A. Cole, Sarah M. Skye, Jennifer D. Kirsop, Michael A. Fischbach, Valentin Gogonea, J. Mark Brown, W. H. Wilson Tang, Stanley L. Hazen
Published 2020-02-01

Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort

by Chayakrit Krittanawong, Yiming Luo, Dhruv Mahtta, Bharat Narasimhan, Zhen Wang, Hani Jneid, Jacqueline E. Tamis-Holland, Alam Mahboob, Usman Baber, Roxana Mehran, W.H. Wilson Tang, Christie M. Ballantyne, Salim S. Virani
Published 2020-10-01

A case series of cardiac amyloidosis patients supported by continuous‐flow left ventricular assist device

by Varinder K. Randhawa, Andrej Gabrovsek, Edward G. Soltesz, Michael Z.Y. Tong, Shinya Unai, Leway Chen, Maria M. Mountis, W.H. Wilson Tang, Randall C. Starling, Jerry D. Estep, Mazen Hanna
Published 2021-10-01

Telocinobufagin, a Novel Cardiotonic Steroid, Promotes Renal Fibrosis via Na+/K+-ATPase Profibrotic Signaling Pathways

by David J. Kennedy, Fatimah K. Khalaf, Brendan Sheehy, Malory E. Weber, Brendan Agatisa-Boyle, Julijana Conic, Kayla Hauser, Charles M. Medert, Kristen Westfall, Philip Bucur, Olga V. Fedorova, Alexei Y. Bagrov, W. H. Wilson Tang
Published 2018-08-01